KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Share-based Compensation (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Share-based Compensation for 6 consecutive years, with $24.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation fell 15.94% year-over-year to $24.9 million, compared with a TTM value of $103.7 million through Dec 2025, down 9.34%, and an annual FY2025 reading of $103.7 million, down 9.34% over the prior year.
  • Share-based Compensation was $24.9 million for Q4 2025 at Clover Health Investments, down from $26.1 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $46.8 million in Q3 2021 and bottomed at $24.9 million in Q4 2025.
  • Average Share-based Compensation over 5 years is $34.3 million, with a median of $33.1 million recorded in 2023.
  • The sharpest move saw Share-based Compensation skyrocketed 3018.12% in 2021, then fell 25.43% in 2024.
  • Year by year, Share-based Compensation stood at $31.2 million in 2021, then rose by 25.38% to $39.1 million in 2022, then fell by 15.24% to $33.1 million in 2023, then dropped by 10.54% to $29.6 million in 2024, then decreased by 15.94% to $24.9 million in 2025.
  • Business Quant data shows Share-based Compensation for CLOV at $24.9 million in Q4 2025, $26.1 million in Q3 2025, and $26.2 million in Q2 2025.